实用医学杂志 ›› 2022, Vol. 38 ›› Issue (4): 473-478.doi: 10.3969/j.issn.1006⁃5725.2022.04.015

• 临床研究 • 上一篇    下一篇

血浆髓样细胞触发受体2联合终末期肝病模型评分对乙型肝炎病毒相关慢加急性肝衰竭患者近期预后的预测价值

柳梅 亓敏 丁雷 郇娟 韩永峰   

  1. 山东第一医科大学附属济南人民医院感染科(济南 271100)

  • 出版日期:2022-02-25 发布日期:2022-02-25
  • 基金资助:
    山东省医药卫生科技发展计划(编号:2018WS109)

Energy efficiency of plasma TREM⁃2 combined with MELD score in predicting the near⁃term prognosis ofpatients with HBV⁃acute⁃on⁃chronic liver failure

LIU Mei,QI Min,DING Lei,YING Juan,HAN Yongfeng.   

  1. Infectious Disease Department,Jinan People′s Hospital,Shandong First Medical University,Ji’nan 271100,China

  • Online:2022-02-25 Published:2022-02-25

摘要:

目的 探讨血浆髓样细胞触发受体 2(TREM⁃2)联合终末期肝病模型(MELD)评分对乙型肝炎病毒相关慢加急性肝衰竭(HBV⁃ACLF)患者近期预后的预测价值。方法 选取2019年1月-2021年1月我院收治的 142 例 HBV⁃ACLF 患者为 HBV⁃ACLF 组,随访 90 d 根据患者结局分为死亡组(n = 52)和存活组(n = 90),另选取同期 58 名体检健康者为对照组。ELISA 法检测血浆白介素⁃6(IL⁃6)、白介素⁃8(IL⁃8)、髓样细胞触发受体 2(TREM⁃2)水平,计算 HBV⁃ACLF 患者 MELD 评分。分析 HBV⁃ACLF 患者血浆 TREM⁃2 与IL⁃6、IL⁃8 水平的相关性。多因素 logistic 回归分析 HBV⁃ACLF 患者近期预后不良影响因素。ROC 曲线分析血浆TREM⁃2水平联合MELD评分对HBV⁃ACLF患者近期预后的预测价值。结果 与对照组比较,HBV⁃ACLF 组血浆 IL⁃6,IL⁃8,TREM⁃2 水平升高(P < 0.05)。HBV⁃ACLF 患者血浆 TREM⁃2 与 IL⁃6,IL⁃8 水平呈正相关(r/rs = 0.762、0.857,均 P < 0.001)。中性粒细胞比值、总胆红素、血肌酐、国际标准化比值、MELD 评分、IL⁃6、IL⁃8、TREM⁃2 为 HBV⁃ACLF 患者近期预后不良的独立危险因素(P < 0.05)。TREM⁃2、MELD 评分、TREM⁃2+MELD 评分预测 HBV⁃ACLF 患者近期预后的曲线下面积分别为 0.771、0.795、0.858,TREM⁃2+MELD 评分预测 HBV⁃ACLF 患者近期预后的曲线下面积大于 TREM⁃2,MELD 评分单独预测(P < 0.05)。结论 血浆TREM⁃2水平和MELD评分升高为HBV⁃ACLF患者近期预后不良的独立危险因素,血浆TREM⁃2联合MELD 评分能提升HBV⁃ACLF 患者近期预后不良的预测价值。

关键词:

乙型肝炎病毒, 慢加急性肝衰竭, 髓样细胞触发受体2, 终末期肝病模型, 预后

Abstract:

Objective To investigate the energy efficiency of plasma triggering receptor expressed on my⁃eloid cell 2(TREM⁃2)combined with model for end⁃stage liver disease(MELD)score in predicting the near⁃termprognosis of patients with hepatitis B virus⁃acute⁃on⁃chronic liver failure(HBV⁃ACLF). Methods A total of 142patients with HBV⁃ACLF admitted to our hospital from January 2019 to January 2021 were selected as the HBV⁃ACLF group,and were divided into a death group(n = 52)and a survival group(n = 90)according to patientoutcomes at 90 d follow⁃up,and another 58 physically healthy individuals were selected as the control group duringthe same period. Plasma interleukin ⁃ 6(IL ⁃6),IL8,and TREM ⁃2 levels were measured by ELISA and MELDscores were calculated. Pearson/Spearman correlation coefficient was used to analyze the correlation between plasmaTREM⁃2 and the levels of IL⁃6 and IL⁃8 in HBV⁃ACLF patients. Multivariate logistic regression was used to analyzefactors influencing the poor prognosis of HBV ⁃ACLF patients in the near future. The predictive value of plasmaTREM⁃2 levels combined with the MELD score for the near⁃term prognosis of HBV⁃ACLF patients was analyzedusing ROC curves. Results Plasma IL⁃6,IL⁃8 and TREM⁃2 levels were significantly elevated in the HBV⁃ACLFgroup compared to the control group(P < 0.05). Plasma TREM⁃2 was positively correlated with the levels of IL⁃6and IL⁃8 in HBV⁃ACLF patients(r/rs = 0.762,0.857,all P < 0.001). Neutrophil ratio,total bilirubin,bloodcreatinine,international normalized ratio,MELD score,IL⁃6,IL⁃8 and TREM⁃2 were independent risk factors forpoor prognosis of the HBV⁃ACLF patients in the near future(P < 0.05).The areas under the curve for the TREM⁃2,MELD score,and TREM ⁃ 2 + MELD score predicting the near ⁃term prognosis of the HBV ⁃ACLF patients were 0.771,0.795,and 0.858,respectively,and the area under the curve for the TREM ⁃2 + MELD score predictingthe near ⁃ term prognosis of HBV ⁃ ACLF patients was significantly greater than that predicted by the TREM ⁃ 2,MELD score alone(P < 0.05). Conclusion Plasma TREM⁃2 levels and elevated MELD scores are independentrisk factors for poor prognosis of HBV ⁃ ACLF patients in the near future,and plasma TREM ⁃ 2 combined withMELD scores enhances the predictive value of poor prognosis of the patients in the near future.

Key words:

hepatitis B virus, acute?on?chronic liver failure, triggering receptor expressed on myeloid cell 2, model for dnd?stage liver disease, prognosis